IQ-AI Limited provided revenue guidance for the financial year 2024. The new financial year has started off well, and revenue to date is higher than the comparable period in 2023. If this trend continues, the company expects to exceed last year's revenue.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 GBX | -4.17% | -14.81% | -75.53% |
06-14 | IQ-AI Says Brain Cancer Drug Delays Disease Progression in Early-stage Study | MT |
06-14 | IQ-AI team begins defining phase 2 protocol for oral gallium maltolate | AN |
1st Jan change | Capi. | |
---|---|---|
-75.53% | 3.38M | |
-17.74% | 8.18B | |
+68.25% | 4.32B | |
+5.67% | 2.74B | |
-2.98% | 2.62B | |
-51.24% | 1.95B | |
-19.04% | 1.67B | |
-22.51% | 1.41B | |
+16.69% | 1.2B | |
-44.81% | 1.12B |
- Stock Market
- Equities
- IQAI Stock
- News IQ-AI Limited
- IQ-AI Limited Provides Revenue Guidance for the Financial Year 2024